Listed by the USPTO as KAPUSHOC, STEPHEN THOMAS
Tech Center 1700 • Art Units: 1634 1682 1683 1699 1758
This examiner grants 47% of resolved cases
KAPUSHOC, STEPHEN THOMAS has resolved 745 cases in tech center 1700 and art unit 1634. The allowance rate is 46.6%, while the interview lift is 53.7%. The interview measure exceeds the allowance result, making interview preparation a potentially important component of prosecution strategy. The median time to allowance is 1379 days, so applicants should plan around an extended examination process.
The recorded companies include Mcmaster University, Natera Inc., and Wisconsin Alumni Research Foundation. Listed firms are FOLEY & LARDNER LLP, WOLF GREENFIELD & SACKS, P.C., and AMPACC Law Group, PLLC. This substantial case record and recurring participant history can support focused preparation for applications in the relevant technology area.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18756518 | ASSESSING GRAFT SUITABILITY FOR TRANSPLANTATION | Non-Final OA | Natera, Inc. |
| 17926804 | EPIGENETIC MODIFICATION OF SELECT GENES AS MARKERS OF HYPERSOMNOLENCE | Final Rejection | Wisconsin Alumni Research Foundation |
| 18168955 | METHODS OF DETERMINING COVID-19 MORTALITY RISK | Non-Final OA | WASHINGTON UNIVERSITY |
| 17776822 | METHODS OF SYNTHESIZING RNA MOLECULES | Final Rejection | BAYER HEALTHCARE LLC |
| 18258485 | IDENTIFICATION AND TREATMENT OF PATIENTS WITH EPILEPSY | Final Rejection | Jazz Pharmaceuticals Research UK Limited |
| 18362013 | SEQUENCE CONVERSION AND SIGNAL AMPLIFIER DNA HAVING ABASIC NUCLEIC ACIDS, AND DETECTION METHODS USING SAME | Final Rejection | ABBOTT LABORATORIES |
| 18426589 | GENE ANALYSIS METHOD AND KIT FOR GENE ANALYSIS | Non-Final OA | HITACHI, LTD. |
| 18435731 | NUCLEIC ACID SEQUENCE ANALYSIS | Non-Final OA | Arizona Board of Regents on behalf of Arizona State University |
| 18332933 | Hybridization Chain Reaction Methods for In Situ Molecular Detection | Non-Final OA | President and Fellows of Harvard College |
| 17794269 | AN EPIGENETIC CLOCK FOR GALLIFORMES | Final Rejection | EVONIK OPERATIONS GMBH |
| 17435728 | METHODS OF DETECTING AND TREATING VENETOCLAX-RESISTANT ACUTE MYELOID LEUKEMIA | Final Rejection | The Regents of the University of Colorado, A Body Corporate |
| 18042167 | BIOMARKERS FOR CANCER THERAPY USING MDM2 ANTAGONISTS | Final Rejection | OTSUKA PHARMACEUTICAL CO., LTD. |
| 19125204 | LIBRARY PREPARATION AND ANALYTICAL METHODS FOR PRESERVING TOPOLOGICAL INFORMATION OF CELL-FREE DNA | Non-Final OA | Roche Sequencing Solutions, Inc. |
| 18691868 | APPARATUSES, SYSTEMS, AND METHODS FOR DETECTING BIOMARKERS ASSOCIATED WITH RISK OF PRESSURE INJURIES | Non-Final OA | CASE WESTERN RESERVE UNIVERSITY |
| 17920652 | METHOD FOR DETECTING SEVERITY OF PREMENSTRUAL SYNDROME | Final Rejection | KAO CORPORATION |
| 18334221 | TL1A THERAPY COMPOSITIONS AND METHODS OF TREATMENT THEREWITH | Final Rejection | CEDARS-SINAI MEDICAL CENTER |
| 18270684 | HIGH-SPATIAL-RESOLUTION EPIGENOMIC PROFILING | Non-Final OA | YALE UNIVERSITY |
| 18698630 | METHODS AND KITS FOR DIAGNOSING MUSCLE ATROPHY | Non-Final OA | CENTRE HOSPITALIER UNIVERSITAIRE DE CLERMONT-FERRAND |
| 18267038 | DIAGNOSTICS AND THERAPEUTICS FOR EBV IN MS AND OTHER AUTOIMMUNE DISEASES | Non-Final OA | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS |
| 18681271 | COMPOSITIONS AND METHODS FOR FAST MULTIPLEXED SCREENING AND MONITORING OF NPM1 MUTATIONS | Non-Final OA | The University of Hong Kong |
| 16837476 | STRATIFICATION OF RISK OF VIRUS ASSOCIATED CANCERS | Non-Final OA | GRAIL, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy46.6% of resolved applications examined by Stephen Thomas Kapushoc were allowed (745 resolved cases), compared with 30.2% across Art Unit 1634 over the last five years.
This examiner's interview lift is +53.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Stephen Thomas Kapushoc took 1,379 days on average from filing to allowance.
Stephen Thomas Kapushoc examines applications in Art Unit 1634 in Tech Center 1700 (Chemistry & Materials).